PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults, Alexander Guminski, Axel Hauschild, Karl D. Lewis, Christine H. Chung, Leonel Hernandez-Aya, Annette M. Lim, Anne Lynn S. Chang, Guilherme Rabinowits, Alesha A. Thai, Lara A. Dunn, Brett G.M. Hughes, Nikhil I. Khushalani, Badri Modi, Dirk Schadendorf, Bo Gao, Frank Seebach, Siyu LiJingjin Li, Melissa Mathias, Jocelyn Booth, Kosalai Mohan, Elizabeth Stankevich, Hani M. Babiker, Irene Brana, Marta Gil-Martin, Jade Homsi, Melissa L. Johnson, Victor Moreno, Jiaxin Niu, Taofeek K. Owonikoko, Kyriakos P. Papadopoulos, George D. Yancopoulos, Israel Lowy, Matthew G. Fury

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalThe New England Journal of Medicine
DOIs
StatePublished - Jun 4 2018

Disciplines

  • Medicine and Health Sciences
  • Endocrinology, Diabetes, and Metabolism
  • Surgery
  • Oncology

Cite this